Anika Therapeutics, Inc. (ANIK)
15.11
-0.01
(-0.07%)
USD |
NASDAQ |
May 07, 15:26
Anika Therapeutics Profit Margin (Quarterly) : -17.07% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| TELA Bio, Inc. | -43.32% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| Masimo Corp. | 13.95% |
| Lantheus Holdings, Inc. | 13.30% |
| Evolus, Inc. | -14.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.69% |
| Return on Assets | -5.83% |
| Return on Invested Capital | -6.54% |
| Gross Profit Margin (Quarterly) | 64.15% |
| Operating Margin (Quarterly) | -18.53% |
| Return on Net Operating Assets | -9.32% |